Osteoarthritis

Evidence-Based Rheumatology

Volumn , Issue , 2009, Pages 141-181

  Pham, Thao ^a   Fransen, Marlene ^b   Ravaud, Philippe ^c   Dougados, Maxime ^d  

^a HÔPITAL DE LA CONCEPTION   (France)

^b Institute for International Health   (Australia)

^c BICHAT HOSPITAL   (France)

^d Institut Cochin   (France)

Author keywords

Cochrane Library and osteoarthritis; Glucosamine, chondroitin, and manganese combination; Non steroidal anti inflammatory drugs (NSAIDS); NSAIDs versus coxibs; Osteoarthritis (OA) and wear and tear of joints; Simple analgesics versus coxibs; Simple analgesics versus NSAIDS; Symptomatic efficacy of chondroitin sulphate in OA; Systematic quality assessment and meta analysis; Total hip arthroplasty (THA) and total knee replacement (TKR) surgery

Indexed keywords

EID: 12344257862     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444315844.ch7     Document Type: Chapter

References (146)

1. Towheed T, Shea B, Wells G, Hochberg M. Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. Cochrane Database Syst Rev (2): CD000517, 2000. Available at: http://www.cochrane.org
2. Watson MC, Brookes ST, Kirwan JR, Faulkner A. Nonaspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee. Cochrane Database Syst Rev (2): CD000142, 2000. Available at: http://www.cochrane.org
3. Amadio P Jr, Cummings DM. Evaluation of acetaminophen in the management of osteoarthritis of the knee. Curr Ther Res 1983; 34: 59-66.
4. Riedemann PJ, Bersinic S, Cuddy J, Torrance GW, Tugwell PX. A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a metaanalysis. J Rheumatol 1993; 20: 2095-103.
5. Simpson J, Golding DN, Freeman AM, et al. A large multicentre, parallel group, double-blind study comparing tenoxicam and piroxicam in the treatment of osteoarthritis and rheumatoid arthritis. Br J Clin Pract 1989; 43: 328-33
6. Dieppe P, Chard J, Faulkner A, Lohmander S. Osteoarthritis. Clin Evidence 1999; 2: 437-48.
7. Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group. BMJ 1998; 317(7157): 526-30.
8. Pincus T, Koch GG, Sokka T, et al. A randomised, doubleblind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001; 44(7): 1587-98.
9. Altman RD for the IAP Study Group. Ibuprofen, acetaminophen and placebo in osteoarthritis of the knee: a six-day double-blind study. Arthritis Rheum 1999; 42: S403.
10. Temple AR, Reel LJ, Fox TM, Lynch JM. Long term use of acetaminophen in osteoarthritis pain. Ann Rheum Dis 2000; 59: 135.
11. Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ; Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomised trial. JAMA 2002; 287(1): 64-71.
12. Peloso PM. Opioid therapy for osteoarthritis of the hip and knee: use it or lose it? J Rheumatol 2001; 28(1): 6-11.
13. Shamoon M, Hochberg MC. Treatment of osteoarthritis with acetaminophen: efficacy, safety, and comparison with nonsteroidal anti-inflammatory drugs. Curr Rheumatol Rep 2000; 2(6): 454-8.
14. Gotzsche PC. Non-steroidal anti-inflammatory drugs. BMJ. 2000; 320(7241): 1058-61.
15. Bombardier C. An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol 2002 21; 89(6A): 3D-9D
16. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000; 43(2): 378-85.
17. Shamoon M, Hochberg MC. The role of acetaminophen in the management of patients with osteoarthritis. Am J Med 2001; 110(3 suppl 1): 46-9.
18. Hochberg MC, Dougados M. Pharmacological therapy of osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15(4): 583-93.
19. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (1): CD002946, 2001.
20. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357: 251-6.
21. Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999; 26: 2423-30.
22. Rindone JP, Hiller D, Collacott E, Nordhaugen N, Arriola Randomised, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med 2000; 172: 91-4.
23. Hughes R, Carr A. A randomised, double-blind, placebocontrolled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology 2002; 41: 279-84.
24. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanalysis. JAMA 2000; 283(11): 1469-75.
25. Mazieres B, Combe B, Phan Van A, Tondut J, Grynfeltt M. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol 2001; 28: 173-81.
26. Leffler CT, Philippi AF, Leffler SG, Mosure JC, Kim PD. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomised, double-blind, placebo-controlled pilot study. Mil Med 1999; 164: 85-91
27. Das A Jr, Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 2000; 8: 343-50.
28. Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, Wigler I, Rosner IA, Beaulieu AD. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum 2000; 43(10): 2339-48.
29. Nguyen M, Dougados M, Berdah L, Amor B. Diacerein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994; 37(4): 529-36.
30. Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M. ECHODIAH Investigators Study Group. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebocontrolled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001; 44(11): 2539-47.
31. Lequesne M, Maheu E, Cadet C, Dreiser RL. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Care Res 2002; 47(1): 50-8.
32. Maheu E, Mazieres B, Valat JP, et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomised, double-blind, placebocontrolled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum 1998; 41(1): 81-91.
33. Pavelka K, Gatterova J, Gollerova V, Urbanova Z, Sedlackova M, Altman RD. A 5-year randomised controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cartilage 2000; 8(5): 335-42.
34. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000; 43(9): 1905-15.
35. American College of Rheumatology, Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 Update. Arthritis Rheum 2000; 43: 1905-15.
36. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 936-44.
37. Fransen M, McConnell S, Bell M. Therapeutic exercise for people with osteoarthritis of the hip or knee. A systematic review. J Rheumatol 2002; 29(8): 1737-45.
38. Petrella RJ. Is exercise effective treatment for osteoarthritis of the knee? Br J Sports Med 2000; 34: 326-31.
39. van Baar ME, Assendelft WJ, Dekker J, Oostendorp RA, Bijlsma JW. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee. Arthritis Rheum 1999; 42: 1361-9.
40. Bautch J, Malone D, Vailas A. Effects of exercise on knee joints with osteoarthritis: a pilot study of biologic markers. Arthritis Care Res 1997; 10: 48-55.
41. Deyle GD, Henderson NE, Matekel RL, Ryder MG, Garber MB, Allison SC. Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomised, controlled trial. Ann Intern Med 2000; 132: 173-81.
42. Ettinger WH, Burns R, Messier SP, et al. A randomised trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA 1997; 277: 25-31.
43. Fransen M, Crosbie J, Edmonds J. Physical Therapy is effective for patients with osteoarthritis of the knee: a randomised controlled clinical trial. J Rheumatol 2001; 28: 156-64.
44. Hopman-Rock M, Westhoff M. The effects of a health educational and exercise program for older adults with osteoarthritis of the hip or knee. J Rheumatol 2000; 27: 1947-54.
45. Kovar PA, Allegrante JP, MacKenzie CR, Peterson MG, Gutin B, Charlson ME. Supervised fitness walking in patients with osteoarthritis of the knee. A randomised, controlled trial. Ann Intern Med 1992; 116: 529-34.
46. Maurer BT, Stern AG, Kinossian B, Cook KD, Schumacher HR. Osteoarthritis of the knee: isokinetic quadriceps exercise versus an educational intervention. Arch Phys Med Rehab 1999; 80: 1293-9.
47. Minor MA, Hewett JE, Webel RR, Anderson SK, Kay DR. Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1989; 32: 1396-405.
48. O'Reilly SC, Muir KR, Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Ann Rheum Dis 1999; 58: 15-19.
49. Peloquin L, Bravo G, Gauthier P, Lacombe G, Billiard J-S. Effects of a cross-training exercise program in persons with osteoarthritis of the knee. A randomised controlled trial. J Clin Rheumatol 1999; 5: 126-36.
50. Petrella RJ, Bartha C. Home based exercise therapy for older patients with knee osteoarthritis: a randomised clinical trial. J Rheumatol 2000; 27(9): 2215-21.
51. Rogind H, Bibow-Nielsen B, Jensen B, Moller HC, Frimodt-Moller H, Bliddal H. The effects of a physical training program on patients with osteoarthritis of the knees. Arch Phys Med Rehab 1998; 79: 1421-7.
52. Schilke JM, Johnson GO, Housh TJ, O'Dell JR. Effects of muscle-strength training on the functional status of patients with osteoarthritis of the knee joint. Nursing Research. 1996; 45: 68-72.
53. van Baar ME, Dekker J, Oostendorp RA, et al. The effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a randomised clinical trial. J Rheumatol 1998; 25: 2432-9.
54. Cohen J. Statistical power analysis for the behavioural sciences, rev. ed. New York: Academic Press, 1977.
55. Baker KR, Nelson ME, Felson DT, Layne JE, Sarno R, Roubenoff R. The efficacy of home-based progressive strength training in older adults with knee osteoarthritis: a randomised controlled trial. J Rheumatol 2001; 28: 1655-65.
56. Gur H, Cakin N, Akova B, Okay E, Kucukoglu S. Concentric versus combined concentric-eccentric isokinetic training: effects on functional capacity a symptoms in patients with osteoarthrosis of the knee. Arch Phys Med Rehab 2002; 83: 308-16.
57. Verhagen AP, de Vet HCW, de Bie RA, Dessels AGH, Boers M, Knipschild PG. Balneotherapy for rheumatoid arthritis and osteoarthritis (Cochrane Review). In: Cochrane Collaboration. Cochrane Library. Issue 2, Oxford: Update Software; 2002.
58. Hart DJ, Doyle DV, Spector TD. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum 1999; 42(1): 17-24.
59. Spector TD, Dacre JE, Harris PA, Huskisson EC. Radiological progression of osteoarthritis: an 11 year follow up study of the knee. Ann Rheum Dis 1992; 51(10): 1107-10.
60. Hill CL, Gale DG, Chaisson CE, Skinner K, Kazis L, Gale ME, Felson DT. Knee effusions, popliteal cysts, and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol 2001; 28(6): 1330-7.
61. Pavelka K, Gatterova J, Pavelka K Sr, et al. Correlation between knee roentgenogram changes and clinical symptoms in osteoarthritis. Rev Rheum 1992; 59(9): 553-9.
62. Fernandez-Madrid F, Karvonen RL, Teitge RA, Miller PR, Negendank WG. MR features of osteoarthritis of the knee. Magn Reson Imaging 1994; 12: 703-9.
63. Claessens AA, Schouten JS, van den Ouweland FA, Valkenburg HA. Do clinical findings associate with radiographic osteoarthritis of the knee? Ann Rheum Dis 1990; 49(10): 771-4.
64. Dougados M, Gueguen A, Nguyen M, et al. Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol 1992; 19(3): 378-84.
65. Ledingham J, Regan M, Jones A, Doherty M. Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis 1995; 54(1): 53-8.
66. Ayral X, Ravaud P, Bonvarlet JP, et al. Arthroscopic evaluation of post-traumatic patellofemoral chondropathy. J Rheumatol 1999; 26: 1140-7.
67. Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 1999; 11(5): 417-21.
68. Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how? Ann Rheum Dis 1997; 56(11): 634-6.
69. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15(4): 609-26.
70. Kirwan JR, Rankin E. Intra-articular therapy in osteoarthritis. Baillieres Clin Rheumatol 1997; 11(4): 769-94.
71. Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 1996; 55(11): 829-32.
72. Towheed TE, Hochberg MC. A systematic review of randomised controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum 1997; 26(5): 755-70.
73. Gotzche P. Methodology and overt hidden bias in reports of 196 double-blind trials of non-steroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials 1989; 10: 31-56.
74. Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol 1980; 7(6): 850-6.
75. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15(4): 609-26.
76. Miller JH, White J, Norton TH. The value of intra-articular injections in osteoarthritis of the knee. JBJS 1958; 4013: 636-43.
77. Wright V, Chandler GN, Morison RA, Hartfall SJ. Intraarticular therapy in osteoarthritis. Comparison of hydrocortisone acetate and hydrocortisone tertiarybutyacetate. Ann Rheum Dis 1960; 19: 257-61.
78. Cederlof S, Jonson G. Intraarticular prednisolone injection for osteoarthritis of the knee. A double blind test with placebo. Acta Chir Scand 1966; 132: 532-6.
79. Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double blind study. J Rheum 1980; 7: 850-6.
80. Dieppe PA, Sathapatayavongs B, Jones HE, et al. Intraarticular steroids in osteoarthritis. Rheumatol Rehabil 1980; 19: 212-17.
81. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis 1995; 54: 379-381.
82. Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no predictors of response. Ann Rheum Dis 1996; 55: 829-32.
83. Ravaud P, Moulinier L, Giraudeau B, et al. Effects of joint lavage and steroids injection in patients with osteoarthritis of the knee. Arthritis Rheum 1999; 42: 475-82.
84. Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop 2001; 385: 130-43.
85. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomised clinical trial. Hyalgan Study Group. J Rheumatol 1998; 25(11): 2203-12.
86. Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995; 3(4): 213-25.
87. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomised, double-blind, placebo-controlled clinical trial. Arch Intern Med 2002; 162(3): 292-8.
88. Bellamy N, Campbell J, Wells G, Bourne R. Intra-articular corticosteroids for osteoarthritis of the knee [Protocol]. Cochrane Database Syst Rev (2), 2002; available at: http://www.cochrane.org
89. Bellamy N, Campbell J, Wells G, Bourne R. Viscosupplementation for osteoarthritis of the knee [Protocol]. Cochrane Database Syst Rev (2), 2002; available at: http://www.cochrane.org
90. Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 1996; 55(11): 829-32.
91. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15(4): 609-26.
92. Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol 1980; 7(6): 850-6.
93. Kirwan JR, Rankin E. Intra-articular therapy in osteoarthritis. Baillieres Clin Rheumatol 1997; 11(4): 769-94.
94. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis 1995; 54: 379-81.
95. Ayral X, Ravaud P, Bonvarlet JP, et al. Arthroscopic evaluation of post-traumatic patellofemoral chondropathy. J Rheumatol 1999; 26: 1140-7.
96. Creamer P. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol 1999; 11(5): 417-21.
97. Weitoft T, Uddenfeldt P. Importance of synovial fluid aspiration when injecting intra-articular corticosteroids. Ann Rheum Dis 2000; 59(3): 233-5.
98. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M. Importance of placement of intra-articular steroid injections. BMJ 1993; 307: 1329-30.
99. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic trials (ESCISIT). Ann Rheum Dis 2000; 59: 936-44.
100. Hochberg MC, Altman RD, Brandt KD, Moscowitz RW. Design and conduct of clinical trials in osteoarthritis: preliminary recommendations from a task force of the Osteoarthritis Research Society. J Rheumatol 1997; 24: 792-4.
101. Maillefert JF, Hudry C, Baron G, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a prospective randomised controlled study. Osteoarthritis Cart 2001; 9: 738-45.
102. Pham T, Maillefert JF, Hudry C, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a two-year prospective randomised controlled study. Ann Rheum Dis 2002; 61(suppl 1): 40 (abstract).
103. Toda Y, Segal N, Kato A, Yamamoto S, Irie M. Effect of a novel insole on the subtalar joint of patients with medial compartment osteoarthritis of the knee. J Rheumatol 2001; 28: 2705-10.
104. Sasaki T, Yasuda K. Clinical evaluation of the treatment of osteoarthritic knees using a newly designed wedged insole. Clin Orthop 1987; 221: 181-7.
105. Ogata K, Yasunaga M, Nomiyama H. The effects of wedged insoles on the thrust of osteoarthritic knees. Int Orthop 1997; 21: 308-12.
106. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995; 38: 1541-6.
107. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 1988;109(1):18-24.
108. Felson DT, Zhang Y, Hannan MT, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum 1997;40(4): 728-33.
109. Spector TD, Hart DJ, Doyle DV. Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population: the effect of obesity. Ann Rheum Dis 1994;53(9):565-8.
110. Schouten JS, van den Ouweland FA, Valkenburg HA. A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 1992;51(8):932-7.
111. Balint G, Szebenyi B. Non-pharmacological therapies in osteoarthritis. Baillieres Clin Rheumatol 1997;11(4): 795-815.
112. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med 1992;116:535-9.
113. O'Reilly S, Doherty M. Lifestyle changes in the management of osteoarthritis. Best Pract Res Clin Rheumatol 2001;15(4):559-68.
114. Williams RA, Foulsham BM. Weight reduction in osteoarthritis using phentermine. Practitioner 1981; 225(1352):231-2.
115. Messier SP, Loeser RF, Mitchell MN, et al. Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study. J Am Geriatr Soc 2000;48(9):1062-72.
116. Huang MH, Chen CH, Chen TW, Weng MC, Wang WT, Wang YL. The effects of weight reduction on the rehabilitation of patients with knee osteoarthritis and obesity. Arthritis Care Research 2000;13:398-405.
117. McGoey BV, Deitel M, Saplys RJ, Kliman ME. Effect of weight loss on musculoskeletal pain in the morbidly obese. J Bone Joint Surg Br 1990;72(2):322-3.
118. Toda Y, Toda T, Takemura S, Wada T, Morimoto T, Ogawa R. Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 1998;25(11): 2181-6.
119. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43(9):1905-15.
120. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995;38(11):1541-6.
121. Young NL, Cheah D, Waddell JP, et al. Patient characteristics that affect the outcome of total hip arthroplasty: a review. Can J Surg 1998;41:188-95.
122. Chan CL, Villar RN. Obesity and quality of life after primary hip arthroplasty. J Bone Joint Surg Br 1996;78:78-81.
123. Espehaug B, Havelin LI, Engesaeter LB, Langeland N, Vollset SE. Patient-related risk-factors for early revision of total hip replacements. A population register-based case-control study of 674 revised hips. Acta Orthop Scand 1997;68:207-215.
124. Pelletier JP, Martel-Pelletier J. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage. Drugs 1993;46 Suppl 1:34-9.
125. Pelletier JP, Mineau F, Fernandes J, Kiansa K, Ranger P, Martel-Pelletier J. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL- 6 while increasing PAI-1, in human OA synovial fibroblasts. Clin Exp Rheumatol 1997;15(4):393-8.
126. Huskisson EC, Berry H, Gishen P, Jubb RW, Whitehead J. Effects on antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. J.Rheumatol 1995;22(10):1941-6.
127. Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walkes F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989;2(8662): 519-22.
128. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993;36(9):1196-206.
129. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (1):CD002946, 2001.
130. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6.
131. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomised, placebo-controlled, double-blind study. Arch Intern Med 2002;162(18):2113-23.
132. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995;38(11):1541-6.
133. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43(9): 1905-15.
134. Uebelhart D, Thonar EJ, Delmas PD, Chantraine A, Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 1998;6 Suppl A:39-46.
135. Mathieu P. Radiological progression of internal femorotibial osteoarthritis in gonarthrosis. Chondro-protective effect of chondroitin sulfates ACS4-ACS6. Presse Med 2002;31(29):1386-90.
136. Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M. ECHODIAH Investigators Study Group. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebocontrolled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001;44(11):2539-47.
137. Lequesne M, Maheu E, Cadet C, Dreiser RL. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Care Research 2002;47(1):50-8.
138. Pavelka K, Gatterova J, Gollerova V, Urbanova Z, Sedlackova M, Altman RD. A 5-year randomised controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cartilage 2000;8(5):335-42.
139. NIH consensus conference: Total hip replacement. NIH Consensus Development Panel on Total Hip Replacement. JAMA 1995;273(24):1950-6.
140. Hawker GA, Wright JG, Coyte PC, et al. Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med 2000;342(14):1016-22.
141. Maillefert JF, Gueguen A, Nguyen M, et al. A composite index for total hip arthroplasty in patients with hip osteoarthritis. J Rheumatol 2002;29(2):347-52.
142. Dieppe P, Basler HD, Chard J, et al. Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization. Rheumatology 1999;38:73-83.
143. Hadorn D, Holmes A The New Zealand priority criteria project Part 1: Overview. BMJ 1997;314:131.
144. Manusco CA, Ranwat CS, Esdaile JM, Johanson NA, Charlson ME. Indications for total hip and total knee arthroplasties. Results of orthopaedic surveys. J Arthroplasty 1996;1:4-46.
145. Naylor CD, Williams JI. Primary hip and knee replacement surgery: Ontario criteria for case selection and surgical priority. Qual Health Care 1996;5:20-30.
146. Woolhead GM, Donovan JL, Chard JA, Dieppe PA. Who should have priority for a knee joint replacement? Rheumatology 2002;41(4):390-4.